Artwork
iconShare
 
Manage episode 493380849 series 123124
Content provided by American Society for Microbiology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Society for Microbiology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

A common description of antibiotic action aims to classify them between “bactericidal” or “bacteriostatic”. Although these phenomena have robust in vitro foundations, the clinical translation of these concepts is sometimes difficult to ascertain. This controversial topic has important conceptual ramifications to treat severe infections. Today, we will discuss this topic with an expert in field.

Watch the video version here: https://youtu.be/3z4BItBrzbk

Topics discussed:
  • The definitions of “cidal” vs “static” antibiotics
  • The clinical applicability of the above terms in terms of antibiotic choice and syndromatic approaches
  • antibiotic choices and the controversy between bactericidal and bacteriostatic antibiotics.
Guest:
  • Brad Spellberg, MD. Chief Medical Officer at the Los Angeles General Medical Center
Links:

This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal.

Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.

  continue reading

105 episodes